author-photo

Niklas Finnberg

Fox Chase Cancer Center

50

Papers

1001

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Abstract 1866: Small molecule NSC59984 is a radio-sensitizer dependent on ERK2 and DDR but independent of wild-type p53

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 96: Didhydropyrimdine dehydrogenase (DPYD) provides resistance to 5-flurouracil in mutant p53 (mtp53) expressing colorectal cancer cells

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5713: PIGN gene expression aberration weakens chromosomal stability via altering its interaction with the spindle assembly checkpoint protein complex during leukemogenesis

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase ( DPYD ) expression in response to thymidylate synthase (TS) targeting

2017 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (12)
PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (8)
Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (9)
Abstract 3706: p53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression following thymidylate synthase (TS) inhibition

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (26)
Abstract PR03: P53 inhibits the expression of the pyrimidine catabolic gene Dihydropyrimidine dehydrogenase (DPYD)

2016 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (5)